The trademark TOBIRA THERAPEUTICS was filed by Tobira Therapeutics, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on August 11, 2008, and received one opposition filed on October 28, 2008 by Novartis Vaccines and Diagnostics, Inc. on Likelihood of confusion. the opponent was represented by FRIEDRICH GRAF VON WESTPHALEN & PARTNER MBB and proceedings were handled in English, and the oppositon was dismissed by the Euorpean Union Intellectual Property Office with decision issued October 28, 2008
The application was filed in English, and English was also language of all opposition proceedings (French was selected as the second language).
The renewal of the trademark was recorded by the office on April 25, 2018.
Change of name and address of the trademark registration was recorded on June 1, 2010. Change of name and professional address of the trademark registration was recorded on May 6, 2013. Change of name and professional address of the trademark registration was recorded on May 6, 2014. Change of name and address of the trademark registration was recorded on December 30, 2014. Change of name and professional address of the trademark registration was recorded on February 24, 2016. Total Surrender of the trademark registration was recorded on October 30, 2018.